Jubilant Pharmova Gets USFDA Nod for New Spokane Fill-Finish Line
MM Desk
24 August, 2026
Jubilant Pharmova Limited has announced that the US Food and Drug Administration (USFDA) has approved
Jubilant Pharmova Limited has announced that the US Food and Drug Administration (USFDA) has approved
Jubilant Pharmova Limited reported a 17% year-on-year increase in revenue to ₹2,229 crore for the
Jubilant Pharmova Limited announced its financial results for the quarter and full year ended March
Jubilant Biosys Innovative Research Services Pte. Limited (JBIRSPL), a Singapore-based subsidiary of Jubilant Biosys Limited,
Jubilant Pharmova Ltd announced a 65% increase in consolidated net profit, reaching Rs 102.5 crore
Jubilant Pharmova Ltd announced on Friday, August 16, that its subsidiary, Jubilant Biosys Ltd, through
Jubilant Pharmova Ltd reported a huge increase in its net profit for the first quarter,